Industry

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of serious nervous system disorders, today announced the publication of new research describing the successful design, screening and characterization of splice modulating antisense oligonucleotides (ASOs) as a potential therapeutic approach for SPG49/HSAN9 (spastic paraplegia 49, more recently classified as … [Read more…]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Noreen Roth Henig, M.D., Chief Medical Officer, will participate in a panel called “Developing Therapies Against Novel Targets in Autoimmune Diseases” at the William Blair Biotech Focus Conference … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on July 7, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on October 14, 2022, to shareholders of record as of September 15, 2022. About Thermo Fisher Scientific Thermo Fisher … [Read more…]

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted … [Read more…]

​​The trial, conducted at UCSF’s TrPR Lab, is first to use naturally derived psychedelic drug candidates and first to directly administer psilocin, the active form of psilocybin SAN FRANCISCO–(BUSINESS WIRE)–$FH #MentalHealth—Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”), a clinical-stage natural psychedelic drug development company, today announced the beginning of dosing in the first United States … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–#LSBCawards–Life Sciences BC (LSBC) is pleased to announce the recipients of the 24th Annual Life Sciences BC Awards, presented by Farris. These awards recognize the achievements of individuals, companies, and organizations that have had success in advancing successful health innovations and contribute to BC’s life sciences ecosystem. According to the report B.C. … [Read more…]

MONTRÉAL–(BUSINESS WIRE)–In a few short weeks, the international community of world leaders, scientists, researchers, community and civil society advocates, service providers, private sector, and philanthropic partners will gather in Montréal, Canada for the biennial International AIDS Conference (AIDS 2022; July 29 – Aug 2). As a vital and long-standing forerunning event, the 9th International Indigenous … [Read more…]

MARTINSVILLE, Ind.–(BUSINESS WIRE)–#Medicaid—Pinnacle Treatment Centers, a leader in providing affordable, accessible treatment for adults struggling with substance use issues, is jumpstarting the development of a withdrawal management (detox) unit at Indiana University Health Morgan in Martinsville, IN. Pinnacle’s unit, named Recovery Works Morgan, will be dedicated to comprehensive care for patients needing assistance with drug … [Read more…]

MEMPHIS, Tenn.–(BUSINESS WIRE)–Dr. Rudolph Jackson, MD, a pioneering researcher of sickle cell disease in the early years of St. Jude Children’s Research Hospital®, was honored at St. Jude as supporters and Dr. Jackson’s family members attended a June 23 event, which celebrated the more than $2 million raised through the ongoing Dr. Rudolph Jackson Campaign … [Read more…]

Telehealth leader announces the use of innovative medical technology in combination with RestoreHealth, the company’s comprehensive metabolic disease support program, to improve health outcomes and reduce financial impact. NEEDHAM, Mass.–(BUSINESS WIRE)–#behavioralhealth—Zillion announced today its partnership with Dexcom, the leader in real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use with … [Read more…]